The adipose tissue (AT) has a major role in contributing to obesity-related pathologies through regulating systemic immuno-metabolism. The pathogenicity of the AT is underpinned by its remarkable plasticity to be reprogrammed under the condition of obesity, in the perspectives of tissue morphology, extracellular matrix (ECM) composition, angiogenesis, immuno-metabolic homeostasis and circadian rhythmicity. Dysregulation in these features escalates the pathogenesis conferred by this endo-metabolic organ. Intriguingly, the potential to be reprogrammed appears to be an Achilles' heel of the obese AT that can be targeted for the management of obesity and its associated comorbidities. Here, we provide an overview of the reprogramming processes of white AT (WAT), with a focus on their dynamics and pleiotropic actions over local and systemic homeostasis, followed by a discussion of potential strategies favouring therapeutic reprogramming. The potential involvement of AT remodelling in the pathogenesis of COVID-19 is also summarized and discussed.